Fermentation
By adjusting culture medium before inoculation, the protein yield and biomass of Bodetella spp. The problem of difficulty in growing and toxin expression in high concentrations is solved, and efficient PT production is achieved and the improvement of vaccine ingredients.
Patent Information
- Application Number
- CN202080029811.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-02-22
- Filing Date
- 2020-02-20
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2040-02-20
AI Technical Summary
The prior art has insufficient efficacy in mass production of Bodetella virulence factors, especially pertussis toxin (PT), and Bodetella is difficult to grow at high concentrations, resulting in its role as a multivalent vaccine. Difficulty in expression of restriction antigens.
By performing a medium adjustment step before inoculation, including maintaining the growth medium at a temperature of 28°C to 35°C and agitating and aeration, an oxygen volume mass transfer coefficient (kLa) of 10 h-1 to 130 h-1 is produced (kLa) , to produce conditions to grow culture medium, increase the protein yield and biomass of Bordetella genus, and reduce fermentation time.
It significantly improves the yield and biomass of Bordetella proteins, shortens the fermentation time, improves the yield of PT, and enhances the immunogenicity and production efficiency of the vaccine.
Smart Images

Figure CN113785046B_ABST
Abstract
Description
[0001] background
[0002] Bordetella Bordetella ) are the causative agents of many bacterial diseases, for example Bordetella pertussis (also known as Haemophilus pertussis) is the cause of whooping cough, a respiratory disease that can be serious in infants and young children. The clinical course of the disease is characterized by episodes of rapid coughing followed by inspiratory efforts that are often associated with a characteristic "whooping" sound. In severe cases, lack of oxygen can lead to brain damage; however, the most common complication is secondary pneumonia.
[0003] Whooping cough is generally considered to be caused by Bordetella pertussis ( B. pertussis ), but Bordetella parapertussis is sometimes isolated from patients with typical signs and symptoms of pertussis ( B. parapertussis ). Bordetella parapertussis infection is less frequent than Bordetella pertussis, with 5-10% of pertussis being associated with Bordetella parapertussis (Mertsola (1985) Eur J Clin Microbiol 4: 123; Lautrop (1971) Lancet 1(7711):1195-1198). Bordetella parapertussis is associated with mild clinical symptoms, which, combined with its serological cross-reaction with Bordetella pertussis, makes Bordetella parapertussis difficult to diagnose.
[0004] The first generation of vaccines against Bordetella pertussis were whole cell vaccines consisting of whole killed bacteria. These were introduced in many countries in the 1950s and 1960s and were successful in reducing the incidence of pertussis. The problem with whole cell Bordetella pertussis vaccines is the high reactogenicity associated with them. Acellular vaccines containing purified Bordetella pertussis proteins have lower reactogenicity and have been adopted in vaccination programs in many countries. Acellular vaccines containing pertussis toxin (PT), filamentous hemagglutinin (FHA) and quite often, pertactin (PRN) are widely used and provide effective protection against the severity of pertussis.
[0005] The Bordetella virulence factors used in these vaccines are produced by fermenting Bordetella and isolating the resulting virulence factors, but Bordetella species ( Bordetella species) are fastidious organisms that are difficult to grow at high concentrations (Doern, Clin. Infect. Dis. 2000, 30:166-173), and it is difficult to express Bordetella virulence factors, particularly pertussis toxin (PT), which serve as limiting antigens in multivalent pertussis vaccines.
[0006] There remains a need in the art to improve the efficiency of Bordetella fermentation and virulence factor production, especially PT production, for large-scale production. The inventors have unexpectedly discovered that a media conditioning step performed prior to inoculation significantly improves several measures of Bordetella fermentation performance at large scale, including increased PT production, increased biomass, and reduced fermentation time. SUMMARY OF THE INVENTION
[0008] In a first aspect of the present invention, there is provided a method for producing a conditioned growth medium, comprising:
[0009] a) providing growth medium;
[0010] b) maintaining the growth medium at a temperature of about 28°C to about 35°C for about 20 to 35 hours; and
[0011] c) optionally stirring and / or aerating the growth medium to produce a 10 h -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa),
[0012] The conditioned growth medium is thereby provided.
[0013] More particularly, a first aspect of the present invention provides a method for producing a sterile conditioned growth medium, comprising:
[0014] a) provide sterile growth medium;
[0015] b) maintaining the sterile growth medium at a temperature of about 28°C to about 35°C for about 20 to 35 hours; and
[0016] c) stirring and / or aerating the sterile growth medium to produce a 10 h -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa),
[0017] The sterile conditioned growth medium is thereby provided.
[0018] In a second aspect of the present invention, there is provided a conditioned growth medium produced by a method comprising the following steps:
[0019] a) providing growth medium;
[0020] b) maintaining the growth medium at a temperature of about 28°C to about 35°C for about 20 to 35 hours; and
[0021] c) optionally stirring and / or aerating the growth medium to produce a 10 h-1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa).
[0022] More particularly, a second aspect of the invention provides a sterile conditioned growth medium produced by a method comprising the steps of:
[0023] a) provide sterile growth medium;
[0024] b) maintaining the sterile growth medium at a temperature of about 28°C to about 35°C for about 20 to 35 hours; and
[0025] c) stirring and / or aerating the sterile growth medium to produce a 10 h -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa).
[0026] In a third aspect of the present invention, there is provided a method for culturing Bordetella species, comprising:
[0027] a) inoculating the conditioned growth medium of the second aspect with at least one Bordetella cell to produce a Bordetella culture; and
[0028] b) maintaining the Bordetella culture under conditions that increase biomass and / or produce at least one Bordetella protein.
[0029] In a fourth aspect of the present invention, there is provided a method for producing a Bordetella protein, comprising:
[0030] a) inoculating the conditioned growth medium of the second aspect with at least one Bordetella cell to produce a Bordetella culture;
[0031] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0032] c) isolating said at least one Bordetella protein from said culture.
[0033] In a fifth aspect of the present invention, there is provided an isolated Bordetella protein produced by a method comprising the steps of:
[0034] a) inoculating the conditioned growth medium of the second aspect with at least one Bordetella cell to produce a Bordetella culture;
[0035] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0036] c) isolating said at least one Bordetella protein from said culture.
[0037] In a sixth aspect of the present invention, there is provided an immunogenic composition comprising an isolated Bordetella protein produced by a method comprising the steps of:
[0038] a) inoculating the conditioned growth medium of the second aspect with at least one Bordetella cell to produce a Bordetella culture;
[0039] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0040] c) isolating said at least one Bordetella protein from said culture. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 : Biomass (solid line) and oxygen consumption (dots) during fermentation of Bordetella in conditioned (black) and unconditioned (grey) medium.
[0043] Figure 2 : Surface plots of the experimental design evaluating the effects of conditioning process parameters on four measures of Bordetella fermentation performance: (A) PT content; (B) FHA content; (C) biomass; and (D) fermentation time. The results predict that the optimal conditioning parameters for PT yield and biomass production are at a temperature of 31.2°C and approximately 90 h. -1 The kLa was down-regulated at 34.6 h.
[0044] Figure 3 : Validation of regulatory parameters at 1 L bioreactor scale. Right: Bordetella fermentations performed in conditioned medium (methods 2, 3 and 4; see Example 3 for details) produced >10% higher PT content than fermentations performed in unconditioned medium. Left: Biomass content was not significantly affected by temperature or kLa at 1 L bioreactor scale.
[0045] Figure 4 : Effect of conditioning duration on PT content and biomass at 1L bioreactor scale. Top: Medium conditioning for 32 and 56 h resulted in an increase in PT content during fermentation compared to unconditioned medium. > 10%. Bottom: Biomass increased at 32 and 56 hours.
[0046] Figure 5: Validation of optimal regulation parameters at 20 L bioreactor scale. Fermentations performed under optimal process parameters (31°C; 32h; kLa 90h-1) in conditioned medium produced at least 10% increase in PT production compared to non-conditioned medium (NC) or suboptimal regulation parameters.
[0047] Figure 6 : Average growth curves with error bars (standard deviation) after fermentation in small-scale vessels (<1 L) using medium conditioned in the 800 L fermentor or media preparation tank.
[0048] Figure 7: Average growth curves with error bars (standard deviation) after fermentation in small-scale vessels (<1 L) using (A) medium conditioned for 32 hours in an 800-L fermentor vs. unconditioned medium or (B) medium conditioned for 32 hours in a media preparation tank vs. unconditioned medium.
[0049] Figure 8 : Average growth curves with error bars (standard deviation) after fermentation in small-scale vessels (<1 L) using medium conditioned in the medium preparation tank for 20 or 32 hours.
[0050] Details
[0051] The present invention is based on the unexpected observation that the addition of a media conditioning step prior to inoculation significantly improves several measures of Bordetella fermentation performance, including increased production of Bordetella protein, increased biomass, and reduced fermentation time. The step or method is particularly performed using a sterile growth medium. More particularly, the step or method is an aseptic process. Even more particularly, the step or method is an aseptic process performed using a sterile growth medium. As used herein, the term "aseptic process" refers to methods and conditions that prevent contamination by excluding microorganisms.
[0052] The term "conditioning" as used herein refers to a process in which a sterile growth medium is treated prior to inoculation with bacteria, in other words conditioning is performed in the absence of bacteria and the medium is sterile. Conditioning is a process that generally includes an aeration and / or stirring phase of the sterile growth medium to improve the performance of the subsequent fermentation step. In particular, the sterile growth medium remains sterile during the duration of the conditioning process. Therefore, preferably, the method for producing the conditioned growth medium of the present invention is an aseptic process. Preferably, the method of the present invention is an aseptic process for producing a sterile conditioned growth medium.
[0053] Thus, one aspect of the invention is a method of producing a conditioned growth medium comprising: providing a growth medium; maintaining the growth medium at a temperature of about 28° C. to about 35° C. for about 20 to 35 hours; and optionally agitating and / or aerating the growth medium to produce a conditioned growth medium for about 10 hours.-1 Up to about 130 hours -1 The present invention provides a method for producing a conditioned growth medium, particularly a sterile method, comprising: providing a sterile growth medium; maintaining the sterile growth medium at a temperature of about 28° C. to about 35° C. for about 20 to 35 hours; and optionally stirring and / or aerating the sterile growth medium to produce a conditioned growth medium for about 10 h. -1 Up to about 130h -1 The oxygen volumetric mass transfer coefficient (kLa) of 100% is used to provide a conditioned growth medium. The conditioned growth medium generated by this method from the sterile growth medium is itself sterile, i.e., does not contain independently replicating living organisms.
[0054] The growth medium can be any medium capable of supporting the growth of Bordetella cells. In certain embodiments, the growth medium is a chemically defined Stainer Scholte (SS) medium or a modified Stainer Scholte medium (MSS). The composition of the Stainer Scholte medium is described in Cohen and Wheeler, American Journal of Public Health (1946) 36: 371-376. If it contains substantially the same concentrations of the same medium components as the SS medium, but contains 1 to 5 modifications of the concentration of the medium components, lacks 1 to 3 medium components, or contains 1 to 20 additional medium components, the medium is a modified Stainer Scholte medium.
[0055] In a specific embodiment, the modified Stainer and Scholte medium comprises dimethyl-ß-cyclodextrin (e.g., about 1 g / L) and acid hydrolyzed casein (e.g., about 10 g / L). In other embodiments, the modified Stainer and Scholte medium comprises L-cysteine (e.g., about 40 mg / L) in place of L-cystine; an increased sodium L-glutamate concentration (e.g., about 11.84 g / L); a reduced glutathione concentration (e.g., about 150 mg / L); and / or a reduced ascorbic acid concentration (e.g., about 400 mg / L). Thus, in some embodiments, the growth medium is a modified Stainer Scholte medium (MSS). In some embodiments, the growth medium is a modified Stainer and Scholte medium comprising about 1 g / L of dimethyl-ß-cyclodextrin and about 10 g / L of acid hydrolyzed casein. In some embodiments, the growth medium is a modified Stainer and Scholte medium comprising about 40 mg / L L-cysteine instead of L-cystine, about 11.84 g / L sodium L-glutamate, about 150 mg / L glutathione, and / or about 400 mg / L ascorbic acid (e.g., about 400 mg / L).
[0056] Compounds that affect the production of virulence factors by B. pertussis often modulate bvg (Bordetella virulence gene) locus plays a role and is therefore named bvg Regulators (see, e.g., EP2809343B). Thus, in some embodiments, the growth medium may contain at least one selected from niacin, magnesium salts, sulfates, phosphates, carbonates, sucrose, proline, sodium ions at a concentration greater than 100 mM, antifoaming agents, glutathione, and sulfur-containing amino acids. bvg In certain embodiments, bvg The modulator is niacin. In some embodiments, the growth medium is a modified Stainer Scholte medium comprising niacin.
[0057] Adjust process parameters: temperature, duration and kLa
[0058] In one aspect of the invention, conditioning is achieved by maintaining the sterile growth medium at a specified temperature for a specified period of time prior to use in fermentation. In one embodiment, the sterile growth medium is maintained at a temperature of about 28°C to about 35°C. In another embodiment, the sterile growth medium is maintained at a temperature of about 29°C to about 33°C, or about 30°C to about 32°C. In a specific embodiment, the sterile growth medium is maintained at about 29, 30, 31, 32 or 33°C. In additional embodiments, the sterile growth medium is maintained at about 30.0, 30.2, 30.4, 30.6, 30.8, 31.0, 31.2, 31.4, 31.6, 31.8 or 32.0°C.
[0059] In certain embodiments, the sterile growth medium is maintained at the desired temperature for about 20 to 35 hours. In another embodiment, the sterile growth medium is maintained at the desired temperature for about 25 to 35 hours or about 30 to 35 hours. In a specific embodiment, the sterile growth medium is maintained at the desired temperature, for example, at about 31°C for about 29, 30, 31, 32, 33, 34, or 35 hours. In a preferred embodiment, the sterile growth medium is maintained at about 31°C for about 32 hours.
[0060] In certain embodiments, growth medium conditioning is performed at a scale of at least 10 L, at least 100 L, at least 800, or at least 1000 L of growth medium. In specific embodiments, growth medium conditioning is performed at a scale of about 10-100 L, about 100-500 L, about 500-1000 L, about 1000-1500 L, about 1500-2000 L, about 1000 L-2500 L, or about 1500 L-2500 L.
[0061] In some embodiments, the methods of the present invention require maintaining a constant kLa of the sterile growth medium throughout the conditioning process. kLa, the oxygen volumetric mass transfer coefficient, is a measure of the rate at which oxygen enters the culture medium. The higher the kLa, the higher the rate at which oxygen is introduced into the culture medium. Several factors, including culture medium volume and composition, agitation (e.g., stirring), aeration, pressure, and temperature will affect the kLa of a particular growth medium preparation.
[0062] Oxygen can be introduced into the sterile growth medium by agitation (e.g., stirring) and / or aeration (bubbling compressed air through the medium). If there are different oxygen concentrations in the air introduced into the medium, the flow rate should be adjusted to take this into account. For example, if a 100% oxygen supply is introduced into the medium, the flow rate is correspondingly lower. If a gas containing less oxygen than air is introduced into the medium, a higher flow rate can be applied. If aeration is achieved by blowing compressed air through the medium, the compressed air is sterile filtered, particularly via a filter, more particularly a filter having sufficiently small pores to prevent microorganisms or spores from entering the container (e.g., bioreactor, fermenter or medium preparation tank) with the air, preferably a filter with a cutoff value of about 0.2 μm to about 0.45 μm.
[0063] kLa can be measured using methods known in the art, for example as described in Example 1 of US2008 / 0193475. The method involves setting up the bioreactor to the conditions of medium volume, temperature, pressure, agitation and aeration for which kLa is to be measured, gassing out by replacing the air with nitrogen, gassing by resuming air aeration and measuring the rate at which pO2 returns to its steady-state level.
[0064] kLa is calculated by plotting the logarithm (100- pO2%) against time. The angle coefficient of the straight line portion of the graph corresponds to -kLa. Typically, only data from 20% to 80% pO2 are considered.
[0065] The kLa of a medium conditioning step or method is affected by many factors, including the stirring rate and aeration flow rate of the medium. A constant kLa can be maintained, for example, while reducing the stirring rate of the medium and increasing the aeration rate, or vice versa. In one embodiment, both the stirring rate and the aeration rate of the growth medium are constant during the medium conditioning process. In one embodiment, the growth medium is continuously stirred throughout the duration of the conditioning. In another embodiment, the growth medium is continuously aerated throughout the duration of the conditioning. In another embodiment, both stirring and aeration are continuously performed throughout the duration of the conditioning.
[0066] For example, in about 10-200 h -1 10-150 h -1 10-100 h -1 10-80 hours -1 10-50 h -1 10-40 hours -1 10-30 hours -1 , 20-150 h -1 , 20-100 h -1 20-50 h -1 20-60 hours -120-80 hours -1 20-30 hours -1 20-40 hours -1 , 30-60 h -1 , 60-80 h -1 , 60-150 h -1 or 60-200 h -1 In certain embodiments, the growth medium is conditioned at about 10 h -1 Up to about 130 hours -1 , about 60 hours -1 Up to about 130 hours -1 , or about 90 h -1 In a preferred embodiment, the growth medium is conditioned at a kLa of about 90 h. -1 .
[0067] For a volume of 10-30 liters, for example, 10-30 h is achieved by using an air flow rate or aeration rate of 1-5 liters / minute and an agitation rate of 200-400 rpm (revolutions per minute), for example 2-4 liters / minute aeration rate and an agitation rate of 250-350 rpm. -1 kLa.
[0068] For a volume of 30-250 liters, for example by using an air flow rate of 15-25 liters / minute and an agitation speed of 150-250 rpm, for example by using an air flow rate of 20-25 liters / minute and an agitation speed of 200-250 rpm, for example by using an air flow rate of 15-20 liters / minute and an agitation speed of 200-250 rpm, a stirring speed of 30-60 h is achieved. -1 kLa.
[0069] In one embodiment, the mixture is heated at about 31°C for about 32 hours, about 90 hours, or about 15 minutes. -1 Growth medium adjustment was performed under kLa.
[0070] The present invention further provides a conditioned growth medium produced by the method of the present invention. The conditioned growth medium is sterile. "Sterile" is intended to indicate that the growth medium contains no or substantially no bacterial cells, for example, prior to inoculation with Bordetella cells.
[0071] Thus, in one aspect, the present invention provides a conditioned growth medium produced by a method, particularly an aseptic method, comprising the steps of:
[0072] a) provide sterile growth medium;
[0073] b) maintaining the sterile growth medium at a temperature of about 28°C to about 35°C for about 20 to 35 hours; and
[0074] c) stirring and / or aerating the sterile growth medium to produce a 10 h -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa).
[0075] In particular, in step c), the sterile growth medium is continuously stirred and / or aerated during the duration of step b). In some embodiments, in step c), the sterile growth medium is continuously stirred during the duration of step b). In other embodiments, in step c), the sterile growth medium is continuously aerated during the duration of step b). In some embodiments, in step c), the sterile growth medium is continuously stirred and aerated during the duration of step b).
[0076] Bordetella fermentation
[0077] In one aspect, the present invention provides a method of culturing a Bordetella species, comprising: inoculating a conditioned growth medium produced as described herein with at least one Bordetella cell to produce a Bordetella culture; and maintaining the Bordetella culture under conditions capable of increasing biomass and / or producing at least one Bordetella protein. In particular, the conditioned growth medium is sterile prior to inoculation with the at least one Bordetella cell.
[0078] In another aspect of the present invention, there is provided a method for producing a Bordetella protein, comprising:
[0079] a) inoculating a conditioned growth medium produced as described herein with at least one Bordetella cell to produce a Bordetella culture;
[0080] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0081] c) isolating said at least one Bordetella protein from said culture.
[0082] Preferably, the method for producing a Bordetella protein comprises:
[0083] a) inoculating a sterile conditioned growth medium produced as described herein with at least one Bordetella cell to produce a Bordetella culture;
[0084] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0085] c) isolating said at least one Bordetella protein from said culture.
[0086] In a further aspect of the invention there is provided an isolated Bordetella protein produced by a method comprising the steps of:
[0087] a) inoculating a conditioned growth medium produced as described herein with at least one Bordetella cell to produce a Bordetella culture;
[0088] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0089] c) isolating said at least one Bordetella protein from said culture.
[0090] Preferably, the isolated Bordetella protein is produced by a process comprising the steps of:
[0091] a) inoculating a sterile conditioned growth medium produced as described herein with at least one Bordetella cell to produce a Bordetella culture;
[0092] b) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and
[0093] c) isolating said at least one Bordetella protein from said culture.
[0094] In some embodiments, the Bordetella species is Bordetella pertussis or Bordetella parapertussis. In one embodiment, the at least one Bordetella protein is selected from pertussis toxin (PT), filamentous hemagglutinin (FHA), pertactin (PRN; also known as 69K) and adenylate cyclase (AC). In a preferred embodiment, the at least one Bordetella protein is pertussis toxin, such as genetically detoxified pertussis toxin (PTg). In some embodiments, the pertussis toxin is a genetically detoxified pertussis toxin in which the two catalytic residues (Arg9 and Glu129) of the S1 subunit are mutated to Lys9 and Gly129 (referred to as PT-9K / 129G mutant).
[0095] The optical density (OD) at 650 nm (also called OD 650) to quantify biomass. In one embodiment, the bacterial density measured at 650 nm at the end of the fermentation reaches at least 10, at least 15, at least 20, at least 30, at least 40, at least 50, at least 60, or at least 70 OD units. Optical density can also be expressed in absorbance units (AU). The end of fermentation is defined as the moment when dissolved oxygen (pO2) in the culture reaches a minimum and begins to climb.
[0096] In another embodiment, the invention provides an immunogenic composition comprising an isolated Bordetella protein produced by the method of the invention.The immunogenic composition of the invention may further comprise one or more pharmaceutically acceptable excipients, adjuvants and / or additional antigens.
[0097] Conditioned growth medium prepared according to the methods of the present invention provides certain advantages in the fermentation of Bordetella cultures. For example, the methods of the present invention can result in the production of at least one Bordetella protein at a yield that is at least 5%, 10%, 15%, 20%, 25% or 30% higher than the yield produced by the same method performed with an unconditioned growth medium. In a specific embodiment, the PT yield is increased by at least 10% compared to the yield produced by the same method performed with an unconditioned growth medium, and the yield of filamentous hemagglutinin is unchanged or higher. The unconditioned growth medium used for comparison is a growth medium that has not been treated or conditioned according to the methods of the present invention, such as a freshly prepared growth medium. Those skilled in the art will recognize that the conditioned growth medium and the unconditioned growth medium used for comparison are of the same type, i.e., can be compared like for like.
[0098] In another embodiment, the fermentation time, defined as the time from inoculation to when the pO2 level reaches a minimum and begins to climb, is at least 10% shorter than the fermentation time of the same process performed with unconditioned growth medium.
[0099] In another embodiment, the Bordetella fermentation process of the invention produces at least 10% greater biomass at the end of the fermentation than the same process performed using unconditioned growth medium.
[0100] In another embodiment, the Bordetella fermentation method of the present invention further comprises the step of purifying one or more Bordetella proteins from the Bordetella culture.
[0101] In one embodiment, the present invention provides an aseptic method for producing a conditioned growth medium, comprising: providing a sterile modified Stainer and Scholte growth medium; maintaining the sterile growth medium at a temperature of about 30-32° C. for about 31-33 hours; and agitating and / or aerating the sterile growth medium to produce a conditioned growth medium for about 90 hours. -1More particularly, an aseptic method for producing a conditioned growth medium comprises: providing a sterile modified Stainer and Scholte growth medium; maintaining the sterile growth medium at a temperature of about 30-32° C. for about 31-33 hours; and agitating and aerating the sterile growth medium to produce a conditioned growth medium for about 90 h. -1 The oxygen volumetric mass transfer coefficient (kLa) is 0.01, thereby providing conditioned growth medium.
[0102] In one embodiment, the present invention provides an aseptic method for producing a conditioned growth medium, comprising: providing a sterile modified Stainer and Scholte growth medium comprising about 1 g / L dimethyl-β-cyclodextrin, about 10 g / L acid hydrolyzed casein, about 40 mg / L L-cysteine instead of L-cystine, about 11.84 g / L sodium L-glutamate; about 150 mg / L glutathione and about 400 mg / L ascorbic acid; maintaining the sterile growth medium at a temperature of about 31° C. for about 32 hours; and stirring and / or aerating the sterile growth medium to produce a conditioned growth medium for about 90 hours. -1 100 mg / L glutathione, and about 400 mg / L ascorbic acid; maintaining the sterile growth medium at a temperature of about 31°C for about 32 hours; and stirring and aerating the sterile growth medium to produce a conditioned growth medium for about 90 hours. -1 The oxygen volumetric mass transfer coefficient (kLa) is 0.01, thereby providing conditioned growth medium.
[0103] Specific Implementation
[0104] Embodiment 1. A method of producing a conditioned growth medium, comprising: (i) providing a growth medium; (ii) maintaining the growth medium at a temperature of about 28° C. to about 35° C. for about 20 to 35 hours; and (iii) optionally agitating and / or aerating the growth medium to produce a conditioned growth medium for about 10 hours. -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa) is 0.01, thereby providing conditioned growth medium.
[0105] Embodiment 2. The method of Embodiment 1, wherein step b) is performed at a temperature of about 29°C to about 33°C, about 30°C to about 32°C, or about 31°C.
[0106] Embodiment 3. The method of embodiments 1-2, wherein step b) is performed for about 25 to 35 hours, about 30 to 35 hours, or about 32 hours.
[0107] Embodiment 4. The method of embodiments 1-3, wherein step c) comprises continuously stirring the growth medium during the duration of step b).
[0108] Embodiment 5. The method of embodiment 4, wherein the stirring is performed for about 60 h -1 Up to about 130 hours -1 , or about 90 h -1 At a stirring speed of 1.5 % oxygen volumetric mass transfer coefficient (kLa).
[0109] Embodiment 6. The method of embodiments 1-5, wherein step c) comprises continuously aerating the growth medium during the duration of step b).
[0110] Embodiment 7. The method of embodiment 6, wherein the aeration is generated for about 60 h -1 Up to about 130 hours -1 , or about 90 h -1 At a flow rate of oxygen volumetric mass transfer coefficient (kLa).
[0111] Embodiment 8. The method of embodiments 1-7, wherein step c) comprises continuously stirring and aerating the growth medium during the duration of step b).
[0112] Embodiment 9. The method of embodiment 8, wherein the stirring and aeration are performed for about 60 hours. -1 Up to about 130h -1 or about 90 hours -1 The oxygen volumetric mass transfer coefficient (kLa) is determined under stirring speed and flow rate.
[0113] Embodiment 10. The method of embodiments 1-9, wherein the method is performed at a scale of at least 10 L, at least 100 L, or at least 1000 L of growth medium.
[0114] Embodiment 11. A conditioned growth medium produced by the method of embodiments 1-10.
[0115] Embodiment 12. A method of culturing a Bordetella species, comprising: (i) inoculating the conditioned growth medium of embodiment 11 with at least one Bordetella cell to produce a Bordetella culture; and (ii) maintaining the Bordetella culture under conditions capable of increasing biomass and / or producing at least one Bordetella protein.
[0116] Embodiment 13. A method of producing a Bordetella protein, comprising: (i) inoculating the conditioned growth medium of embodiment 11 with at least one Bordetella cell to produce a Bordetella culture; (ii) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and (iii) isolating the at least one Bordetella protein from the culture.
[0117] Embodiment 14. The method of embodiments 12-13, wherein the at least one Bordetella protein is selected from the group consisting of pertussis toxin, filamentous hemagglutinin, pertactin, and adenylate cyclase.
[0118] Embodiment 15. The method of embodiments 12-14, wherein the at least one Bordetella protein is produced at a yield that is at least 10% greater than the yield produced by the same method performed using unconditioned growth medium.
[0119] Embodiment 16. The method of embodiments 12-15, wherein the at least one Bordetella protein is pertussis toxin, such as a genetically detoxified pertussis toxin.
[0120] Embodiment 17. The method of embodiments 12-16, wherein the at least one Bordetella protein is a genetically detoxified pertussis toxin in which two catalytic residues (Arg9 and Glu129) of the S1 subunit are mutated to Lys9 and Gly129.
[0121] Embodiment 18. The method of embodiment 16, wherein the yield of filamentous hemagglutinin is unchanged or increased compared to the yield produced by the same method performed using unconditioned growth medium.
[0122] Embodiment 19. The method of embodiments 12-18, wherein the fermentation time is at least 10% shorter than the fermentation time of the same method performed with non-conditioned growth medium.
[0123] Embodiment 20. The method of embodiments 12-19, wherein the biomass of the Bordetella culture at the end of fermentation is at least 10% greater than the biomass produced by the same method performed using unconditioned growth medium.
[0124] Embodiment 21. The method of embodiments 12-20, wherein the method further comprises the step of purifying one or more Bordetella proteins from the Bordetella culture.
[0125] Embodiment 22. The method of embodiments 1-10, wherein the growth medium is sterile.
[0126] Embodiment 23. An isolated Bordetella protein produced by the method of embodiments 12-22.
[0127] Embodiment 24. An immunogenic composition comprising the isolated Bordetella protein of embodiment 23.
[0128] Embodiment 25. An aseptic method for producing a conditioned growth medium, comprising: (i) providing a sterile growth medium; (ii) maintaining the sterile growth medium at a temperature of about 28° C. to about 35° C. for about 20 to 35 hours; and (iii) agitating and / or aerating the sterile growth medium to produce a conditioned growth medium for about 10 hours. -1 Up to about 130 hours -1 The oxygen volumetric mass transfer coefficient (kLa) is 0.01, thereby providing conditioned growth medium.
[0129] Embodiment 26. The aseptic process of embodiment 25, wherein step b) is performed at a temperature of about 29°C to about 33°C, about 30°C to about 32°C, or about 31°C.
[0130] Embodiment 27. The aseptic process of embodiment 25 or 26, wherein step b) is performed for about 25 to 35 hours, about 30 to 35 hours, or about 32 hours.
[0131] Embodiment 28. The aseptic process of embodiment 25, 26 or 27, wherein step c) comprises continuously stirring the sterile growth medium during the duration of step b).
[0132] Embodiment 29. The aseptic method of embodiment 28, wherein the stirring is performed for about 60 hours. -1 Up to about 130h -1 , or about 90 h -1 At a stirring speed of 1.5 % oxygen volumetric mass transfer coefficient (kLa).
[0133] Embodiment 30. The aseptic process of embodiments 25 to 29, wherein step c) comprises continuously aerating the sterile growth medium during the duration of step b).
[0134] Embodiment 31. The aseptic method of embodiment 30, wherein the aeration is generated for about 60 hours. -1Up to about 130h -1 , or about 90 h -1 At a flow rate of oxygen volumetric mass transfer coefficient (kLa).
[0135] Embodiment 32. The aseptic process of embodiments 25 to 31, wherein step c) comprises continuously stirring and aerating the sterile growth medium during the duration of step b).
[0136] Embodiment 33. The aseptic method of embodiment 32, wherein the stirring and aeration are performed to produce about 60 h -1 Up to about 130 hours -1 or about 90 hours -1 The oxygen volumetric mass transfer coefficient (kLa) is determined under stirring speed and flow rate.
[0137] Embodiment 34. The aseptic process of embodiments 25 to 33, wherein the process is performed at a scale of at least 10 L, at least 100 L, or at least 1000 L of sterile growth medium.
[0138] Embodiment 35. A conditioned growth medium produced by the aseptic method of embodiments 25 to 34.
[0139] Embodiment 36. A method of culturing a Bordetella species, comprising: (i) inoculating the conditioned growth medium of embodiment 35 with at least one Bordetella cell to produce a Bordetella culture; and (ii) maintaining the Bordetella culture under conditions capable of increasing biomass and / or producing at least one Bordetella protein.
[0140] Embodiment 37. A method of producing a Bordetella protein, comprising: (i) inoculating the conditioned growth medium of embodiment 35 with at least one Bordetella cell to produce a Bordetella culture; (ii) maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and (iii) isolating the at least one Bordetella protein from the culture.
[0141] Embodiment 38. The method of embodiment 36 or 37, wherein the at least one Bordetella protein is selected from the group consisting of pertussis toxin, filamentous hemagglutinin, pertactin, and adenylate cyclase.
[0142] Embodiment 39. The method of Embodiment 36, 37 or 38, wherein the at least one Bordetella protein is produced at a yield that is at least 10% greater than the yield produced by the same method performed using unconditioned growth medium.
[0143] Embodiment 40. The method of embodiments 36 to 39, wherein the at least one Bordetella protein is pertussis toxin, such as a genetically detoxified pertussis toxin.
[0144] Embodiment 41. The method of embodiments 36 to 40, wherein the at least one Bordetella protein is a genetically detoxified pertussis toxin in which the two catalytic residues (Arg9 and Glu129) of the S1 subunit are mutated to Lys9 and Gly129.
[0145] Embodiment 42. The method of embodiment 40 or 41, wherein the yield of filamentous hemagglutinin is unchanged or increased compared to the yield produced by the same method performed using unconditioned growth medium.
[0146] Embodiment 43. The method of embodiments 36 to 42, wherein the fermentation time is at least 10% shorter than the fermentation time of the same method performed with non-conditioned growth medium.
[0147] Embodiment 44. The method of Embodiments 36 to 43, wherein the biomass of the Bordetella culture at the end of fermentation is at least 10% greater than the biomass produced by the same method performed with unconditioned growth medium.
[0148] Embodiment 45. The method of Embodiments 36 to 44, wherein the method further comprises the step of purifying one or more Bordetella proteins from the Bordetella culture.
[0149] Embodiment 46. The method of any preceding embodiment, wherein the growth medium is Modified Stainer Scholte's medium (MSS) optionally comprising niacin.
[0150] Embodiment 47. The method of Embodiment 46, wherein the growth medium is a modified Stainer and Scholte medium comprising about 1 g / L dimethyl-β-cyclodextrin and about 10 g / L acid hydrolyzed casein.
[0151] Embodiment 48. The method of embodiment 46 or 47, wherein the growth medium is a modified Stainer and Scholte medium comprising about 40 mg / L L-cysteine instead of L-cystine; about 11.84 g / L L-sodium glutamate; about 150 mg / L glutathione; and / or about 400 mg / L ascorbic acid (e.g., about 400 mg / L).
[0152] Embodiment 49. An aseptic method for producing a sterile conditioned growth medium, comprising: (a) providing a sterile growth medium; (b) maintaining the sterile growth medium at a temperature of about 29° C. to about 33° C., about 30° C. to about 32° C., or about 31° C. for about 25 to 35 hours, about 30 to 35 hours, or about 32 hours; and (c) continuously stirring and / or aerating the sterile growth medium during step b) to produce a sterile conditioned growth medium for about 60 hours. -1 Up to about 130 hours -1 , or about 90h -1 The oxygen volumetric mass transfer coefficient (kLa) is 0.01, thereby providing a sterile conditioned growth medium; wherein the growth medium is a modified Stainer Scholte medium (MSS) optionally comprising niacin.
[0153] General
[0154] Unless otherwise indicated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. The singular terms "a", "an" and "the" include plural references unless the context clearly indicates otherwise. Similarly, the word "or" is intended to include "and" unless the context clearly indicates otherwise.
[0155] In addition, the numerical limits given for the concentration or content of a substance, such as the concentration of a solution component or its ratio, and reaction conditions, such as temperature, pressure, and cycle time, are intended to be approximate values. The term "approximately" as used herein is intended to represent an amount of ±10%. Unless the context otherwise requires, the word "between" when used to represent a numerical range (e.g., "between X and Y" or "between about X and about Y") is intended to include the endpoints of the range (i.e., including X and Y).
[0156] The term "comprising" means "including". Thus, unless the context requires otherwise, the word "comprises" and variations such as "comprise" and "comprising" will be understood to imply the inclusion of the stated compound or composition (e.g., nucleic acid, polypeptide, antigen) or step, or group of compounds or steps, but not the exclusion of any other compound, composition, step, or group thereof. The term "consisting of" means "including and limited to". The term "consisting essentially of" means that the composition or method may include additional ingredients and / or steps, but only if the additional ingredients and / or steps do not materially alter the basic and novel characteristics of the claimed composition or method. The abbreviation "eg" is derived from the Latin exempligratia and is used herein to indicate a non-limiting example. Thus, the abbreviation "eg" is synonymous with the term "for example".
[0157] The invention is further described with reference to the following non-limiting examples and accompanying figures. Example
[0158] Example 1: Verification of culture medium conditioning effect at laboratory scale
[0159] Preliminary observations suggested that yield variation in commercial scale Bordetella fermentations could be attributed to differences in growth medium conditioning prior to inoculation. To explore the source of this variation, the effect of growth medium conditioning prior to inoculation was examined in a bench scale model process.
[0160] Laboratory scale models
[0161] The laboratory scale model was developed to reproduce the three steps of the commercial process: 1) pre-culture train; 2) medium conditioning; and 3) fermentation. The pre-culture train step refers to the pre-culture step used to accumulate sufficient biomass for inoculation of the fermentation step. Since medium conditioning is an aseptic process step performed in the absence of bacteria, medium conditioning is performed independently of the pre-culture train step, e.g., before, after, or in parallel. In the pre-culture, 10 9 B. pertussis CFU were inoculated into a first shake flask preculture containing 30 ml fresh medium (MSS; derived from the medium of Stainer and Scholte. J. Gen. Microbial. 63:211-220 (1971) by adding dimethyl-ß-cyclodextrin 1 g / L and acid hydrolyzed casein 10 g / L, replacing L-cystine 40 mg / L with L-cysteine 40 mg / L, and using higher concentrations of sodium L-glutamate (11.84 g / L), reduced glutathione (150 mg / L), and ascorbic acid (400 mg / L) and incubated at 35°C with agitation at 150 rpm for 24 h. The first preculture was used to inoculate a second shake flask preculture containing 1000 ml fresh medium (MSS). The second preculture was incubated at 35°C with agitation at 150 rpm for 24 h. Aliquots from the preculture sequence were then used to inoculate conditioned growth medium for fermentation as described below.
[0162] Medium conditioning was performed in parallel with the preculture sequence. One liter of sterile growth medium (same type used for preculture) was aseptically transferred into a 1-liter bioreactor (BioBlock platform (4 x 1L bioreactors), Eppendorf) and incubated at 35 °C, bubbling with 20 L of air per hour, and stirring at 430 rpm (60 h -1The cells were kept at 4 °C for 40 h at 4 °C kLa. As a control, unconditioned growth medium was kept at 4 °C without further processing. The preparation of conditioned medium and unconditioned medium was performed four times using the same procedure (Prep 1, Prep 2, Prep 3, Prep 4).
[0163] The conditioned and unconditioned media were inoculated with pre-cultured Bordetella inocula and grown in small-scale fermentation vessels (<1 L) under standard conditions (35 °C, at least 90 h -1 The culture was incubated at 400 μg / mL and the fermentation step was performed on a small scale.
[0164] Measures of fermentation performance
[0165] The evaluation of fermentation performance as shown in biomass, PT production and fermentation time was repeated at least 3 times for each preparation. Online measurements of biomass, dissolved oxygen pressure (pO2) and pH were recorded throughout the fermentation. The start of fermentation was defined as the time when the Bordetella preculture sequence was added to the fermentation vessel. The end of fermentation was defined as the time point when dissolved oxygen (pO2) reached a minimum and began to climb back to 100%. The inflection point of pO2 indicates that the carbon source in the culture is exhausted and the cells transition from the growth phase to the stationary phase. The fermentation time is therefore the amount of time between the start of fermentation and the end of fermentation.
[0166] At the end of the fermentation, the supernatant was recovered by centrifugation (14000g, 10 min RT), filtered (0.22 um filter) and stored at -20 °C for further analysis. The pertussis toxin (PT) content at the end of the fermentation was determined by ELISA using standard methods.
[0167] result
[0168] The results are summarized in Table 1 as the mean percentage change relative to the unconditioned medium [Conditioned / Unconditioned – 1 (%)]. For all four replicates (Preps 1-4), the pertussis toxin content at the end of the fermentation was increased by at least 10% in the conditioned medium compared to the unconditioned medium. For three of the preparations (Preps 2-3), the biomass at the end of the fermentation was correspondingly increased in the conditioned medium compared to the unconditioned medium. Finally, a trend towards a decrease in fermentation time was observed when the cultures were grown in conditioned medium compared to the unconditioned medium.
[0169] Table 1
[0170] .
[0171] The growth kinetics of Prep 2 is shown as a representative example of these four preparations. Figure 1Figure 2. Bordetella cell growth (biomass) in conditioned medium (solid black line) and unconditioned medium (solid grey line) was similar during the first 15-20 hours of culture. Thereafter, the cell growth rate in the conditioned medium was higher than in the unconditioned medium. As biomass increased, dissolved oxygen decreased, with a more rapid decrease observed in the conditioned medium fermentation. At the end of the fermentation, as indicated by the rapid re-increase of dissolved oxygen, biomass was significantly higher in the conditioned medium fermentation conditions than in the unconditioned fermentation conditions.
[0172] Results from initial small-scale studies indicate that prior media conditioning has a positive effect on Bordetella cell growth and PT production. In particular, significant increases in biomass and PT content at the fermentation endpoint were observed for fermentations performed in conditioned media. A trend toward shorter fermentation times in conditioned media was also observed. Results from the bench-scale model confirmed the observations made at commercial scale, indicating that the effect of conditioning is independent of the scale of the fermentation. No significant effects of media conditioning on the pH of the medium were observed during cell growth (data not shown).
[0173] Without being bound by underlying theory, the observed media conditioning effects may be related to biochemical modifications that occur during media conditioning, such as oxidation of one or more media components, which improve cell growth and virulence factor production rates during the fermentation step.
[0174] Example 2: Identification of process parameters affecting medium conditioning
[0175] In order to better determine the regulatory parameters leading to improved Bordetella fermentation performance, a Design of Experiments (DoE) study was performed.
[0176] method
[0177] The effects of three conditioning process parameters on subsequent fermentation performance were evaluated in a central composite design with 3 levels (minimum / central / maximum) for each parameter as shown in Table 2. The process parameters were conditioning temperature, conditioning duration, and oxygen volumetric mass transfer coefficient (kLa), which was a factor of aeration flow rate and agitation speed.
[0178] Table 2: Medium adjustment process parameters
[0179] parameter Minimum center maximum Temperature(℃) 28 35 40 <![CDATA[kLa (h -1 )]]> 10 50 90 Duration (hours) 3 23 43
[0180] The DoE was performed in 60 runs over 6 weeks (see Table 3). Each week, 3 x 1L conditioning bioreactors were loaded with 1L of freshly prepared sterile growth medium as described in Example 1 and conditioned at 3 different kLa-temperatures. During the conditioning process, each conditioning bioreactor was sampled at 3 different time points (3h, 23h and 43h) to examine the effect of conditioning duration. The culture medium samples extracted at 3 and 23h were immediately stored at 4°C to stabilize the samples. After the last sample was extracted, 9 culture medium samples from the 3 bioreactors were transferred to a small-scale fermentation vessel (<1L) and inoculated with a Bordetella preculture sequence prepared as described in Example 1 to evaluate growth and antigen production.
[0181] Fermentation performance indicators were evaluated by measuring PT and FHA content (ELISA), biomass content (growth curve and final optical density) and fermentation time (measured as described in Example 1).
[0182] result
[0183] The results are shown in Table 3 and Figure 2 The changes in conditioning process parameters had different effects on the fermentation performance indicators. The longer the duration of medium conditioning, the better the obtained biomass and PT content. The FHA content was not affected by the increased conditioning duration. Adjusting the temperature affected the PT production but not the growth performance (biomass). Finally, the change in kLa affected the biomass but not the PT production.
[0184] The results of the DoE predict a design space for tuning parameter values associated with an increase in PT (at least 10%) relative to unconditioned medium ( Figure 2 AD). The model also predicted that the optimal regulation parameters for PT yield and biomass production were a temperature of 31.2 °C and approximately 90 h -1 The kLa was down-regulated for 34.6h.
[0185] Table 3: Experimental design results
[0186]
[0187]
[0188] NC : Non-conditional
[0189] NT: Not tested .
[0190] Example 3: Validation of regulatory parameters at 1 L bioreactor scale
[0191] To validate the medium adjustment design space for 10% increased PT production identified in Example 2, medium adjustment and fermentation processes were performed at 1 L bioreactor scale using adjustment parameters within the predicted design space.
[0192] method
[0193] A 4 x 1L-bioreactor platform (BioBlock, Eppendorf) was used for medium conditioning prior to inoculation. The platform allows the parallel conditioning of 4 medium preparations and the continuous evaluation of their fermentation performance. For the conditioning step, 1L of sterile growth medium (see Examples 1 and 2) was aseptically transferred to each bioreactor and subjected to the process parameters described in the experimental design (below). If the experimental design required non-conditioned medium, one of the four bioreactors remained empty during the conditioning step to allow the later transfer of non-conditioned medium (see below).
[0194] When the predetermined duration of medium conditioning was reached, conditioning was stopped. For certain runs, one liter (1 L) of unconditioned medium (prepared as in Examples 1 and 2) was aseptically transferred to one of the four bioreactors. The following conditions were used to calibrate 100% dissolved oxygen (DO) levels in each bioreactor: temperature (35°C), atmospheric pressure, air flow rate (bubbling 2 L of air per minute), and agitation speed (300 rpm or revolutions per minute). 300 µL of antifoam (Simethicone 15%) was aseptically added to each bioreactor.
[0195] Inoculation was achieved by adding 150 mL of Bordetella pertussis inoculum (prepared in parallel with the conditioning step as described in Examples 1 and 2). During the fermentation, the temperature (35°C) was maintained at a constant level. Foam control during the fermentation was performed by adding an antifoaming agent (Simethicone 1.5%). The dissolved oxygen level was set to 35% to compensate for the head pressure applied during larger scale fermentations and was adjusted by increasing agitation when DO dropped below 35%. The minimum agitation speed was set to 300 rpm; the maximum agitation speed was set to 1100 rpm. The pH was adjusted to 7.2 by adding acetic acid 50% (w / v or weight / volume).
[0196] At the end of the fermentation (as defined in Example 1), biomass yield was determined by measuring the optical density and the total amount of acetic acid added by pH adjustment (the latter as an orthogonal method to estimate biomass content). Pertussis toxin (PT) production in the culture supernatant was determined by ELISA using standard methods.
[0197] Experimental design
[0198] In Example 2, a design space that results in at least a 10% increase in PT production was calculated. In this experiment, we compared the fermentation performance (fermentation time, biomass, PT and FHA production) of the medium conditioned under three different process parameters (methods 2-4 in Table 4) within the calculated PT design space relative to the unconditioned medium (method 1 in Table 4). Methods 2 and 3 were tested at 90 h. -1 or 60h -1 The optimal operating parameters for PT production at kLa values (32 h at 31 °C) were tested at a conditioning temperature of 35 °C and 60 h. -1 The experiment was performed once.
[0199] Table 4
[0200] method Duration (hours) Temperature(℃) <![CDATA[kLa (h -1 )]]> 1 32 4 0 2 32 31 90 3 32 31 60 4 32 35 60
[0201] result
[0202] like Figure 3 As shown in Figure 2, fermentations performed in conditioned medium (Methods 2, 3, and 4) produced greater than 10% higher PT content than fermentations performed in unconditioned medium (right graph). Biomass content was not significantly affected by temperature or kLa at 1 L bioreactor scale (left graph). These results validate the design space for 10% increased PT production identified in the experimental design study (Example 2).
[0203] Example 4: Effect of conditioning duration at 1 L bioreactor scale
[0204] In order to explore the effect of conditioning duration over a wider time range, a conditioning temperature of 31 °C and a 90 h -1 Example 3 (Table 5) was repeated with kLa values of <3 h, 32 h or 56 h. The experiment was performed in duplicate.
[0205] Table 5
[0206] method Duration (hours) Temperature(℃) <![CDATA[kLa (h -1 ) <!-- 16 -->]]> 5 32 4 0 6 <3 31 90 7 32 31 90 8 56 31 90
[0207] result
[0208] like Figure 4 As shown in Figure 2, conditioning of the medium for 32 h and 56 h resulted in an increase in PT content compared to unconditioned medium. > 10% (upper graph). Biomass also increased at 32h and 56h (lower graph). The effect of increasing conditioning duration on PT content and biomass reached a plateau around 32h.
[0209] Example 5: Verification of optimal adjustment parameters at 20-liter bioreactor scale
[0210] Optimal media conditioning parameters were also validated in Bordetella fermentations performed at 20 L bioreactor scale.
[0211] method
[0212] A 20 L fermenter (Biolafitte™) was used for medium conditioning prior to inoculation. 10 L of sterile growth medium prepared as in Example 1 was aseptically transferred into the 20 L bioreactor and subjected to the conditioning process parameters summarized in Table 6.
[0213] Table 6
[0214] .
[0215] The preculture sequence was prepared as described in Example 1, except that the first and second precultures were prepared in duplicate (2 x 30 mL first preculture; 2 x 1000 mL second preculture). After 24 h (+ / - 1 h) growth at 35°C (+ / - 1°C) and 150 rpm, two disposable shake flasks from the second preculture were pooled. Once the second preculture was stopped, the pooled precultures were used to inoculate the fermentor.
[0216] Once the predetermined duration of the conditioning step was reached, conditioning was stopped and the following conditions were used to calibrate the 100% dissolved oxygen (DO) level prior to inoculation: temperature (35°C), head pressure (0.4 bar), air flow rate (14.6 L of air per minute), and agitation speed (50 rpm or revolutions per minute). 3 mL of antifoam (Simethicone 15%) was aseptically added to each bioreactor.
[0217] Inoculation was achieved by adding 1.5 L of pooled preculture. During the fermentation, the temperature (35°C) and head pressure (0.4 bar) were kept at constant levels. Foam control during the fermentation was performed by adding an antifoaming agent (Simethicone 1.5%). The dissolved oxygen level was set to 25% and adjusted by increasing agitation when DO dropped below 25%. The minimum agitation speed was set to 50 rpm; the maximum agitation speed was set to 1000 rpm. The pH was adjusted to 7.2 by adding acetic acid 50% (w / v or weight / volume).
[0218] Experimental design
[0219] This experiment was designed to compare the optimal process parameters (31°C, 32h, 90h -1 Fermentation performance of the medium adjusted under the condition of kLa) and the medium adjusted under the condition of only one parameter different from the optimal process parameter.
[0220] In week 1, the effect of the optimal parameters (Schedule 2) was verified relative to the unconditioned medium (Schedule 1). In weeks 2 and 3, the effect of low regulated kLa (Schedule 3 – low aeration and Schedule 5 – low agitation speed) was compared to the optimal operating conditions (Schedules 4 and 6). In weeks 4 and 5, the effects of low temperature (Schedule 7: 23°C) and low duration (Schedule 9: 3h) were compared to the optimal operating parameters (Schedules 8 and 10), respectively.
[0221] result
[0222] like Figure 5 As shown in Table 7A, fermentations performed in conditioned medium with optimal process parameters resulted in 10% higher PT production compared to:
[0223] - Unconditioned medium (week 1)
[0224] - Medium conditioned at low kLa (≈10h-1) caused by low aeration flow rate (week 2)
[0225] - Medium conditioned at low kLa (≈10h-1) caused by low stirring speed (week 3)
[0226] - Medium conditioned with low temperature (23°C) (week 4)
[0227] - Medium conditioned with short duration (3 h) (week 5)
[0228] These data confirm the optimal operating parameters for medium conditioning for PT production at the 20 L fermentation scale. No negative effects were observed on biomass yield, FHA yield, and fermentation time. Surprisingly, while the small-scale studies described in Examples 1-4 did not find an effect of low kLa on PT production, a negative effect of low kLa was observed at the 20 L fermentation scale. Thus, duration, temperature, and kLa all appear to be important factors in producing a conditioning effect at the 20 L fermentation scale.
[0229] Table 7A: Fermentation performance at 20 L scale
[0230]
[0231] NC: non-conditioned growth medium.
[0232] Example 6: Verification of optimal adjustment parameters on a large scale
[0233] Media conditioning parameters were performed at large scale and validated in Bordetella fermentations conducted in small-scale fermentation vessels (<1 L).
[0234] method
[0235] The 800 L fermentor and 2400 L media preparation tank were used for large-scale media conditioning prior to inoculation. The sterile growth medium prepared as in Example 1 was aseptically transferred to the fermentor (800 L) or media preparation tank (2400 L) and subjected to the following media conditioning process parameters (Table 7B). Due to differences between the vessels, such as aeration sparger design and agitation system, the Kla values achieved in the media preparation tank were lower than those obtained in the fermentor.
[0236] Table 7B
[0237]
[0238] * Non-conditioned growth medium (NC) – control.
[0239] Five samples of sterile conditioned medium were collected in Novaseptum sampling bags at different time points and immediately stored at 4 °C.
[0240] Each of the 5 samples was transferred to a small scale fermentation vessel (<1 L) and inoculated with a Bordetella preculture train prepared as described in Example 1 to evaluate growth and antigen production.
[0241] Fermentation performance indicators were evaluated by measuring PT and FHA content (ELISA), biomass content (growth curve and final optical density) and fermentation time (measured as described in Example 1).
[0242] result
[0243] like Figure 6 As shown in Figure 7, regardless of the type of vessel used to perform the conditioning step, media conditioning had a comparable effect on growth performance during the subsequent fermentation step. However, in each case, the use of pre-conditioned media had a demonstrable positive effect on the fermentation (Figure 7 (A) and (B)).
[0244] Faster bacterial growth compared to non-conditioned medium (control) meant that the total fermentation time could be reduced by approximately 8% on average. Using conditioned medium, the final biomass achieved was higher than that of the control (approximately 9% higher at the beginning of stationary phase). Interestingly, the growth performance of the medium conditioned for 20 and 32 hours was comparable ( Figure 8 ).
[0245] Fermentation performed in conditioned medium improved the yields of PT and FHA. Specifically, the PT productivity increased by 7% after 20 hours of medium conditioning and by 15% after 32 hours of medium conditioning relative to the control. Similarly, the FHA productivity increased by 9% after 20 hours of medium conditioning and by 15% after 32 hours of medium conditioning relative to the control.
[0246] Table 8: Summary results of growth performance and antigen productivity. Fermentation time and biomass at the beginning of stationary phase were determined directly from the growth curves.
[0247]
[0248] a – value at the beginning of the stationary phase, determined from the mean growth curve;
[0249] b – OD read on samples stored at 4 °C for 2 days after the end of fermentation.
[0250] These data demonstrate the positive effects of using a cell-free medium conditioning step at large scale (up to 2400 L) before the conditioned medium is used in bacterial fermentation.
Claims
1. An aseptic method for conditioning a growth medium comprising: a). Provide sterile growth medium; b). maintaining the sterile growth medium at a temperature of 28°C to 35°C for 20 to 35 hours; and c) stirring and / or aerating the sterile growth medium to produce 10h -1 Until 130h -1 The oxygen volumetric mass transfer coefficient (kLa), Thereby a conditioned growth medium is provided, wherein the aseptic process is a process performed in the absence of bacteria and the medium is sterile, the growth medium being a medium capable of supporting the growth of Bordetella cells.
2. The method of claim 1, wherein step b) is performed at a temperature of 29°C to 33°C, 30°C to 32°C, or about 31°C; and / or wherein step b) is performed for 25 to 35 hours, 30 to 35 hours, or about 32 hours.
3. The method of claim 1, wherein in step c), the sterile growth medium is continuously stirred during the duration of step b), wherein the stirring produces 60 h -1 Until 130h -1 , or about 90h -1 and / or wherein in step c), the sterile growth medium is continuously aerated during the duration of step b), wherein the aeration produces a 60 h -1 Until 130h -1 , or about 90h -1 and / or wherein step c) comprises continuously stirring and aerating the sterile growth medium during the duration of step b), wherein the stirring and aeration produce a 60 h -1 Until 130h -1 or about 90h -1 The oxygen volumetric mass transfer coefficient (kLa) is determined under stirring speed and flow rate.
4. The method of claim 1, wherein the method is performed at a scale of at least 10 L, at least 100 L, at least 800 L, or at least 1000 L of sterile growth medium.
5. The method of any of the preceding claims, wherein the growth medium is a modified Stainer Scholte medium comprising niacin.
6. The method of claim 5, wherein the growth medium is a modified Stainer and Scholte medium comprising about 1 g / L dimethyl-β-cyclodextrin and about 10 g / L acid hydrolyzed casein; and / or wherein the growth medium is a modified Stainer and Scholte medium comprising about 40 mg / L L-cysteine instead of L-cystine; about 11.84 g / L sodium L-glutamate; about 150 mg / L glutathione; and / or about 400 mg / L ascorbic acid.
7. A method of culturing Bordetella species, comprising: a). inoculating a sterile conditioned growth medium with at least one Bordetella cell to produce a Bordetella culture, wherein the sterile conditioned growth medium is produced by the method of any one of claims 1 to 6; and b). Maintaining the Bordetella culture under conditions that increase biomass and / or produce at least one Bordetella protein.
8. A method for producing a Bordetella protein, comprising: a). inoculating a sterile conditioned growth medium with at least one Bordetella cell to produce a Bordetella culture, wherein the sterile conditioned growth medium is produced by the method of any one of claims 1 to 6; b). maintaining the Bordetella culture under conditions capable of producing at least one Bordetella protein; and c). isolating said at least one Bordetella protein from said culture.
9. The method of claim 7 or 8, wherein the at least one Bordetella protein is selected from the group consisting of pertussis toxin, filamentous hemagglutinin, pertactin, and adenylate cyclase; and / or wherein the at least one Bordetella protein is produced in a yield that is at least 10% greater than the yield produced by the same method performed using unconditioned growth medium.
10. The method of claim 7 or 8, wherein the at least one Bordetella protein is pertussis toxin, and / or wherein the at least one Bordetella protein is or further comprises a filamentous hemagglutinin, wherein the production of filamentous hemagglutinin is unchanged or increased compared to the production produced by the same method performed using unconditioned growth medium.
11. The method of claim 10, wherein the at least one Bordetella protein is a genetically detoxified pertussis toxin, wherein the at least one Bordetella protein is a genetically detoxified pertussis toxin in which two catalytic residues Arg9 and Glu129 of the S1 subunit are mutated to Lys9 and Gly129.
12. The method of claim 7 or 8, wherein the fermentation time is at least 10% shorter than the fermentation time of the same method performed using non-conditioned growth medium; and / or The biomass of the Bordetella culture at the end of fermentation is at least 10% greater than the biomass produced by the same process using unconditioned growth medium.
13. The method of claim 7 or 8, wherein the method further comprises the step of purifying one or more Bordetella proteins from the Bordetella culture.
Citation Information
Patent Citations
Fermentation process
EP2809343A1
Fermentation Process for the Production of Diphtheria Toxin
US20080193475A1
Fermentation process
WO2013113729A1
